|
|
Volumn 23, Issue 11, 2005, Pages 1327-1328
|
|
Sandoz sues FDA over delay in first biogeneric approval
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HUMAN GROWTH HORMONE;
BIOTECHNOLOGY;
DRUG APPROVAL;
DRUG COST;
DRUG INDUSTRY;
DRUG LEGISLATION;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE ORGANIZATION;
HEALTH CARE POLICY;
LAW SUIT;
NOTE;
POLITICS;
PRIORITY JOURNAL;
BIOTECHNOLOGY;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUGS, GENERIC;
HUMAN GROWTH HORMONE;
LEGISLATION, DRUG;
RECOMBINANT PROTEINS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 27944500756
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt1105-1327 Document Type: Note |
|
Times cited : (4)
|
|
References (0)
|